Twelve of 32 (38 %) analyzed thymic carcinomas exhibited a loss of the CDKN2A gene, which was heterozygous in three, homozygous in four and mixed heterozygous/homozygous in five cases (Table 3). Here, CDKN2A is linked to thymic carcinoma.